image credit: Unsplash

Cytiva Acquires Chromatography Resins Manufacturing Facility in Muskegon, Michigan

Cytiva has acquired a new chromatography resins manufacturing site in the United States as part of its $1.5 billion capacity expansion investment.

Cytiva announced on July 13, 2022 that it had acquired a new manufacturing facility in Muskegon, MI. The new facility, a chromatography resins manufacturing site, is part of Cytiva and Pall Corporation’s $1.5 billion capacity expansion investment, allowing Cytiva to expand its resin manufacturing beyond Sweden.

According to a company press release, Cytiva plans to renovate the site into a 168,000 ft² biomanufacturing center consisting of multiple buildings; it will house approximately 200 associates upon completion. With a planned construction start date in Q3 2022, manufacturing is expected to begin in 2026.

Read More on Biopharm International